ArticleMolecular medicine (Cambridge, Mass.)2023

DYNLT1 promotes mitochondrial metabolism to fuel breast cancer development by inhibiting ubiquitination degradation of VDAC1.

Ling Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.